ARCHIVES

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

This article is from The Cancer Letter archive.

Vol. 24 No. 4 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

“Action Steps” Listed For Prostate Research In National Blueprint

January 16, 1998

Severe Shortages Of Many Cancer Drugs Affecting Practices

November 19, 2010

When Is A Cancer Cured? NCI Suggest One-Year Survival Rates Useful In Determining Advances

August 1, 1975

ONS Scientific Program Grows

June 20, 1980

AACI Summarizes Position On New Core Guidelines

May 16, 1980

In Brief: Calabresi Named To President’s Cancer Panel; Mays Leaves NCI Technology Office For IVAX

May 5, 1995